BioMarin Pharmaceutical - 25 Year Stock Price History | BMRN

Historical daily share price chart and data for BioMarin Pharmaceutical since 1999 adjusted for splits and dividends. The latest closing stock price for BioMarin Pharmaceutical as of April 12, 2024 is 92.22.
  • The all-time high BioMarin Pharmaceutical stock closing price was 149.13 on July 20, 2015.
  • The BioMarin Pharmaceutical 52-week high stock price is 100.31, which is 8.8% above the current share price.
  • The BioMarin Pharmaceutical 52-week low stock price is 76.02, which is 17.6% below the current share price.
  • The average BioMarin Pharmaceutical stock price for the last 52 weeks is 89.88.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BioMarin Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 89.3734 98.0500 99.0000 83.8100 92.2200 -4.36%
2023 93.7643 100.6100 117.2700 76.2200 96.4200 -6.83%
2022 86.6013 89.3600 108.6300 71.4800 103.4900 17.14%
2021 80.5858 86.3000 91.4700 71.7200 88.3500 0.75%
2020 91.5134 84.0400 131.0300 71.3700 87.6900 3.71%
2019 82.5653 84.9600 98.6200 64.2700 84.5500 -0.70%
2018 92.1163 91.0300 106.0700 76.0100 85.1500 -4.51%
2017 88.8143 85.8400 98.8200 80.6000 89.1700 7.64%
2016 86.6998 104.9200 104.9200 64.7400 82.8400 -20.92%
2015 117.0456 92.1700 149.1300 90.2800 104.7600 15.88%
2014 70.7528 69.2700 94.1900 55.7800 90.4000 28.50%
2013 63.4324 51.9200 78.3880 51.5600 70.3500 42.99%
2012 39.1417 34.9300 50.1700 32.1300 49.2000 43.11%
2011 28.4184 26.6100 35.3800 23.4600 34.3800 27.66%
2010 22.1536 18.9500 28.2500 18.2400 26.9300 43.17%
2009 15.6685 17.6500 20.8300 10.1400 18.8100 5.67%
2008 29.7800 36.6400 40.3900 13.5900 17.8000 -49.72%
2007 21.0564 16.1000 36.5800 15.7100 35.4000 115.99%
2006 14.3090 10.9900 18.0400 10.9600 16.3900 52.04%
2005 7.3643 6.2600 11.4100 4.4300 10.7800 68.70%
2004 6.2104 7.9100 8.7900 3.8700 6.3900 -17.65%
2003 9.4406 7.0300 13.3200 6.4100 7.7600 10.07%
2002 7.2827 13.2400 13.9500 3.6500 7.0500 -47.54%
2001 11.0435 9.5000 14.1600 7.3130 13.4400 38.73%
2000 18.0555 12.7500 38.7500 7.1560 9.6880 -17.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.405B $2.419B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.240B 14.33
Vertex Pharmaceuticals (VRTX) United States $102.492B 29.50
Regeneron Pharmaceuticals (REGN) United States $99.302B 24.07
Bristol Myers Squibb (BMY) United States $97.852B 6.44
CSL (CSLLY) Australia $88.445B 0.00
Gilead Sciences (GILD) United States $84.752B 10.13
GSK (GSK) United Kingdom $84.265B 10.56
Moderna (MRNA) United States $40.256B 0.00
Biogen (BIIB) United States $28.808B 13.45
Argenex SE (ARGX) Netherlands $22.417B 0.00
BioNTech SE (BNTX) Germany $20.559B 20.99
Illumina (ILMN) United States $20.237B 146.06
Genmab (GMAB) Denmark $19.348B 24.80
Alnylam Pharmaceuticals (ALNY) United States $18.703B 0.00
BeiGene (BGNE) Cayman Islands $13.514B 0.00
Exact Sciences (EXAS) United States $12.950B 0.00
Incyte (INCY) United States $12.091B 20.09
Sarepta Therapeutics (SRPT) United States $11.537B 0.00
Bio-Techne Corp (TECH) United States $10.489B 39.02
Bio-Rad Laboratories (BIO.B) United States $9.655B 28.76
Legend Biotech (LEGN) United States $9.627B 0.00
Repligen (RGEN) United States $9.578B 99.15
QIAGEN (QGEN) Netherlands $9.169B 18.98
Roivant Sciences (ROIV) United Kingdom $8.816B 0.00
Ascendis Pharma (ASND) Denmark $8.503B 0.00
Viking Therapeutics (VKTX) United States $7.563B 0.00
Cytokinetics (CYTK) United States $7.483B 0.00
Exelixis (EXEL) United States $6.916B 35.64
Vaxcyte (PCVX) United States $6.708B 0.00
Intra-Cellular Therapies (ITCI) United States $6.378B 0.00
Apellis Pharmaceuticals (APLS) United States $6.245B 0.00
Blueprint Medicines (BPMC) United States $5.340B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.150B 0.00
Krystal Biotech (KRYS) United States $4.951B 0.00
Halozyme Therapeutics (HALO) United States $4.906B 15.14
Biohaven (BHVN) United States $4.331B 0.00
Zealand Pharma (ZLDPF) Denmark $4.276B 0.00
Immunovant (IMVT) United States $4.264B 0.00
Nuvalent (NUVL) United States $4.197B 0.00
Alkermes (ALKS) Ireland $4.131B 21.80
Insmed (INSM) United States $4.048B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.868B 0.00
Fortrea Holdings (FTRE) United States $3.490B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Iovance Biotherapeutics (IOVA) United States $3.452B 0.00
Axsome Therapeutics (AXSM) United States $3.276B 0.00
Apogee Therapeutics (APGE) United States $3.217B 0.00
Amicus Therapeutics (FOLD) United States $3.155B 0.00
SpringWorks Therapeutics (SWTX) United States $3.154B 0.00
IDEAYA Biosciences (IDYA) United States $3.129B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.116B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.115B 0.00
Arcellx (ACLX) United States $3.095B 0.00
Certara (CERT) United States $2.831B 60.93
ACADIA Pharmaceuticals (ACAD) United States $2.824B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.816B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.805B 0.00
MorphoSys AG (MOR) Germany $2.720B 0.00
Janux Therapeutics (JANX) United States $2.720B 0.00
CG Oncology (CGON) United States $2.649B 0.00
Vera Therapeutics (VERA) United States $2.612B 0.00
Denali Therapeutics (DNLI) United States $2.541B 0.00
Arvinas (ARVN) United States $2.471B 0.00
Merus (MRUS) Netherlands $2.456B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.425B 0.00
Intellia Therapeutics (NTLA) United States $2.333B 0.00
Vericel (VCEL) United States $2.317B 0.00
Guardant Health (GH) United States $2.222B 0.00
Celldex Therapeutics (CLDX) United States $2.194B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.189B 0.00
Kymera Therapeutics (KYMR) United States $2.174B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.174B 0.00
Neumora Therapeutics (NMRA) United States $2.155B 0.00
Beam Therapeutics (BEAM) United States $2.117B 0.00
Keros Therapeutics (KROS) United States $2.109B 0.00
Galapagos (GLPG) Belgium $1.993B 0.00
Geron (GERN) United States $1.991B 0.00
Sana Biotechnology (SANA) United States $1.975B 0.00
Avidity Biosciences (RNA) United States $1.920B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.845B 0.00
Structure Therapeutics (GPCR) United States $1.832B 0.00
NeoGenomics (NEO) United States $1.799B 0.00
Twist Bioscience (TWST) United States $1.774B 0.00
Myriad Genetics (MYGN) United States $1.757B 0.00
Bavarian Nordic (BVNRY) Denmark $1.703B 5.59
Harmony Biosciences Holdings (HRMY) United States $1.675B 13.91
Inhibrx (INBX) United States $1.658B 0.00
Protagonist Therapeutics (PTGX) United States $1.576B 0.00
Dynavax Technologies (DVAX) United States $1.549B 0.00
Edgewise Therapeutics (EWTX) United States $1.524B 0.00
Arcus Biosciences (RCUS) United States $1.507B 0.00
Kura Oncology (KURA) United States $1.483B 0.00
Ligand Pharmaceuticals (LGND) United States $1.441B 17.84
Gyre Therapeutics (GYRE) United States $1.436B 0.00
Morphic Holding (MORF) United States $1.434B 0.00
Zai Lab (ZLAB) China $1.420B 0.00
ANI Pharmaceuticals (ANIP) United States $1.410B 17.33
ADMA Biologics Inc (ADMA) United States $1.374B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.335B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.286B 0.00
AbCellera Biologics (ABCL) Canada $1.271B 0.00
Akero Therapeutics (AKRO) United States $1.249B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.238B 0.00
Immunome (IMNM) United States $1.229B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.221B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.216B 0.00
Vir Biotechnology (VIR) United States $1.206B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.203B 0.00
Prothena (PRTA) Ireland $1.195B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.153B 0.00
MannKind (MNKD) United States $1.123B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.119B 0.00
Belite Bio (BLTE) United States $1.076B 0.00
Liquidia Technologies (LQDA) United States $1.061B 0.00
Scholar Rock Holding (SRRK) United States $1.047B 0.00
Viridian Therapeutics (VRDN) United States $0.997B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.988B 0.00
Kyverna Therapeutics (KYTX) United States $0.982B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.952B 0.00
MiMedx (MDXG) United States $0.946B 214.67
Abivax SA (ABVX) France $0.944B 0.00
89BIO (ETNB) United States $0.918B 0.00
Immatics (IMTX) Germany $0.898B 0.00
REGENXBIO (RGNX) United States $0.887B 0.00
Pliant Therapeutics (PLRX) United States $0.852B 0.00
Nurix Therapeutics (NRIX) United States $0.823B 0.00
Cabaletta Bio (CABA) United States $0.822B 0.00
CARGO Therapeutics (CRGX) United States $0.820B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.819B 0.00
Cytek Biosciences (CTKB) United States $0.807B 0.00
Tango Therapeutics (TNGX) United States $0.785B 0.00
Tyra Biosciences (TYRA) United States $0.782B 0.00
Disc Medicine (IRON) United States $0.768B 0.00
Dianthus Therapeutics (DNTH) United States $0.760B 0.00
HilleVax (HLVX) United States $0.747B 0.00
Praxis Precision Medicines (PRAX) United States $0.730B 0.00
PureTech Health (PRTC) United States $0.730B 0.00
Cullinan Oncology (CGEM) United States $0.718B 0.00
WAVE Life Sciences (WVE) Singapore $0.709B 0.00
Pharming Group (PHAR) Netherlands $0.707B 0.00
Aerovate Therapeutics (AVTE) United States $0.703B 0.00
Pharming Group (PHGUF) Netherlands $0.695B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.692B 0.00
Prime Medicine (PRME) United States $0.687B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.679B 0.00
EnGene Holdings (ENGN) United States $0.671B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.670B 0.00
Oric Pharmaceuticals (ORIC) United States $0.660B 0.00
Absci (ABSI) United States $0.658B 0.00
ALX Oncology Holdings (ALXO) United States $0.653B 0.00
Zymeworks (ZYME) United States $0.653B 0.00
CureVac (CVAC) Germany $0.651B 0.00
Nuvation Bio (NUVB) United States $0.648B 0.00
Mineralys Therapeutics (MLYS) United States $0.646B 0.00
Allogene Therapeutics (ALLO) United States $0.643B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.629B 0.00
Northwest Biotherapeutics (NWBO) United States $0.625B 0.00
Cogent Biosciences (COGT) United States $0.622B 0.00
Mesoblast (MESO) Australia $0.613B 0.00
AnaptysBio (ANAB) United States $0.608B 0.00
Olema Pharmaceuticals (OLMA) United States $0.607B 0.00
Novavax (NVAX) United States $0.599B 0.00
Astria Therapeutics (ATXS) United States $0.594B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.593B 0.00
Stoke Therapeutics (STOK) United States $0.591B 0.00
GH Research (GHRS) Ireland $0.582B 0.00
Alector (ALEC) United States $0.576B 0.00
Fate Therapeutics (FATE) United States $0.573B 0.00
ArriVent BioPharma (AVBP) United States $0.566B 0.00
Celcuity (CELC) United States $0.558B 0.00
Castle Biosciences (CSTL) United States $0.551B 0.00
Applied Therapeutics (APLT) United States $0.546B 0.00
IGM Biosciences (IGMS) United States $0.538B 0.00
Annexon (ANNX) United States $0.538B 0.00
ACELYRIN, INC (SLRN) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Arbutus Biopharma (ABUS) United States $0.522B 0.00
Neurogene (NGNE) United States $0.510B 0.00
C4 Therapeutics (CCCC) United States $0.508B 0.00
Editas Medicine (EDIT) United States $0.508B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.485B 0.00
Travere Therapeutics (TVTX) United States $0.485B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Third Harmonic Bio (THRD) United States $0.469B 0.00
Biomea Fusion (BMEA) United States $0.466B 0.00
Fulcrum Therapeutics (FULC) United States $0.465B 0.00
Mersana Therapeutics (MRSN) United States $0.462B 0.00
Voyager Therapeutics (VYGR) United States $0.458B 2.73
Shattuck Labs (STTK) United States $0.443B 0.00
Ocugen (OCGN) United States $0.439B 0.00
Replimune (REPL) United States $0.438B 0.00
Adaptive Biotechnologies (ADPT) United States $0.437B 0.00
Entrada Therapeutics (TRDA) United States $0.435B 0.00
Nkarta (NKTX) United States $0.432B 0.00
Revance Therapeutics (RVNC) United States $0.430B 0.00
Avid Bioservices (CDMO) United States $0.426B 0.00
PepGen (PEPG) United States $0.421B 0.00
ITeos Therapeutics (ITOS) United States $0.420B 0.00
MaxCyte (MXCT) United States $0.418B 0.00
Jasper Therapeutics (JSPR) United States $0.418B 0.00
Amarin (AMRN) Ireland $0.393B 0.00
Solid Biosciences (SLDB) United States $0.392B 0.00
Adlai Nortye (ANL) Cayman Islands $0.390B 0.00
Alto Neuroscience (ANRO) United States $0.384B 0.00
Caribou Biosciences (CRBU) United States $0.379B 0.00
Aura Biosciences (AURA) United States $0.373B 0.00
Anika Therapeutics (ANIK) United States $0.371B 0.00
TScan Therapeutics (TCRX) United States $0.371B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.362B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.362B 0.00
MeiraGTx Holdings (MGTX) United States $0.357B 0.00
Urogen Pharma (URGN) United States $0.354B 0.00
Precigen (PGEN) United States $0.353B 0.00
Anavex Life Sciences (AVXL) United States $0.353B 0.00
Invivyd (IVVD) United States $0.352B 0.00
Tenaya Therapeutics (TNYA) United States $0.350B 0.00
FibroBiologics (FBLG) United States $0.349B 0.00
Humacyte (HUMA) United States $0.343B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.340B 0.00
Terns Pharmaceuticals (TERN) United States $0.332B 0.00
Ventyx Biosciences (VTYX) United States $0.324B 0.00
CorMedix Inc (CRMD) United States $0.320B 0.00
Rapt Therapeutics (RAPT) United States $0.320B 0.00
Erasca (ERAS) United States $0.320B 0.00
Inozyme Pharma (INZY) United States $0.318B 0.00
Atea Pharmaceuticals (AVIR) United States $0.316B 0.00
Nautilus Biotechnology (NAUT) United States $0.309B 0.00
XOMA (XOMA) United States $0.301B 0.00
Kamada (KMDA) Israel $0.295B 22.35
ChromaDex (CDXC) United States $0.290B 0.00
Verastem (VSTM) United States $0.286B 0.00
Contineum Therapeutics (CTNM) $0.283B 0.00
XBiotech (XBIT) United States $0.282B 0.00
AC Immune (ACIU) Switzerland $0.271B 0.00
Rani Therapeutics Holdings (RANI) United States $0.271B 0.00
Poseida Therapeutics (PSTX) United States $0.263B 0.00
2seventy Bio (TSVT) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Puma Biotechnology (PBYI) United States $0.254B 11.46
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
Coherus BioSciences (CHRS) United States $0.251B 0.00
Cardiff Oncology (CRDF) United States $0.251B 0.00
Adverum Biotechnologies (ADVM) United States $0.243B 0.00
G1 Therapeutics (GTHX) United States $0.238B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.237B 82.40
Kodiak Sciences (KOD) United States $0.232B 0.00
Elevation Oncology (ELEV) United States $0.230B 0.00
UniQure (QURE) Netherlands $0.229B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
X4 Pharmaceuticals (XFOR) United States $0.225B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.225B 0.00
Compass Therapeutics (CMPX) United States $0.223B 0.00
Opthea (OPT) Australia $0.222B 0.00
Scilex Holding (SCLX) United States $0.221B 0.00
Prima BioMed (IMMP) Australia $0.219B 0.00
23andMe Holding (ME) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
Design Therapeutics (DSGN) United States $0.208B 0.00
BioStem Technologies (BSEM) $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
Akoya Biosciences (AKYA) United States $0.203B 0.00
Gossamer Bio (GOSS) United States $0.202B 0.00
Codexis (CDXS) United States $0.202B 0.00
Trevi Therapeutics (TRVI) United States $0.201B 0.00
Greenwich LifeSciences (GLSI) United States $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.201B 0.00
Werewolf Therapeutics (HOWL) United States $0.200B 0.00
Candel Therapeutics (CADL) United States $0.195B 0.00
INmune Bio (INMB) United States $0.187B 0.00
Inventiva S.A (IVA) France $0.186B 0.00
Compugen (CGEN) Israel $0.185B 0.00
Alimera Sciences (ALIM) United States $0.184B 0.00
Lifecore Biomedical (LFCR) United States $0.184B 0.00
LENZ Therapeutics (LENZ) United States $0.182B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.179B 0.00
GENFIT S.A (GNFT) France $0.178B 0.00
ScPharmaceuticals (SCPH) United States $0.178B 0.00
Adicet Bio (ACET) United States $0.177B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.175B 0.00
Agenus (AGEN) United States $0.171B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
Renovaro (RENB) United States $0.157B 0.00
CervoMed (CRVO) United States $0.155B 0.00
Sagimet Biosciences (SGMT) United States $0.154B 0.00
Spyre Therapeutics (SYRE) United States $0.152B 0.00
BioAtla (BCAB) United States $0.151B 0.00
Cellectis S.A (CLLS) France $0.150B 0.00
Omega Therapeutics (OMGA) United States $0.148B 0.00
I-Mab (IMAB) China $0.146B 0.00
CytomX Therapeutics (CTMX) United States $0.146B 0.00
Zura Bio (ZURA) United States $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Syros Pharmaceuticals (SYRS) United States $0.143B 0.00
Repare Therapeutics (RPTX) Canada $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.134B 0.00
VistaGen Therapeutics (VTGN) United States $0.132B 0.00
Coya Therapeutics (COYA) United States $0.132B 0.00
Vor Biopharma (VOR) $0.130B 0.00
Immunic (IMUX) United States $0.130B 0.00
Annovis Bio (ANVS) United States $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.125B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.122B 0.00
TELA Bio (TELA) United States $0.121B 0.00
Bluebird Bio (BLUE) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Vigil Neuroscience (VIGL) United States $0.119B 0.00
ATyr Pharma (LIFE) United States $0.118B 0.00
PDS Biotechnology (PDSB) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
Oncobiologics (OTLK) United States $0.113B 0.00
Genelux (GNLX) United States $0.111B 0.00
Emergent Biosolutions (EBS) United States $0.108B 0.00
Rezolute (RZLT) United States $0.107B 0.00
BioHarvest Sciences (CNVCF) Canada $0.107B 0.00
Cartesian Therapeutics (RNAC) United States $0.105B 0.00
IO Biotech (IOBT) Denmark $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elicio Therapeutics (ELTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.099B 0.00
Alpha Teknova (TKNO) United States $0.098B 0.00
Precision BioSciences (DTIL) United States $0.098B 0.00
Allakos (ALLK) United States $0.098B 0.00
Sangamo Therapeutics (SGMO) United States $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.095B 0.00
Athira Pharma (ATHA) United States $0.094B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.093B 0.00
DiaMedica Therapeutics (DMAC) United States $0.092B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Curis (CRIS) United States $0.090B 0.00
BioXcel Therapeutics (BTAI) United States $0.089B 0.00
Spero Therapeutics (SPRO) United States $0.088B 3.28
InflaRx (IFRX) Germany $0.088B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 0.00
Affimed (AFMD) Germany $0.088B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
Cue Biopharma (CUE) United States $0.085B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Rallybio (RLYB) United States $0.083B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Passage Bio (PASG) United States $0.083B 0.00
Gritstone Bio (GRTS) United States $0.082B 0.00
AN2 Therapeutics (ANTX) United States $0.082B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
YS Biopharma (YS) China $0.080B 0.00
Celularity (CELU) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.078B 0.00
MediciNova (MNOV) United States $0.077B 0.00
Cognition Therapeutics (CGTX) United States $0.076B 0.00
Ocean Biomedical (OCEA) United States $0.076B 0.00
Aligos Therapeutics (ALGS) United States $0.076B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.074B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Turnstone Biologics (TSBX) United States $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.073B 0.00
Immix Biopharma (IMMX) United States $0.073B 0.00
Elutia (ELUT) United States $0.073B 0.00
Instil Bio (TIL) United States $0.071B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.070B 0.00
Lantern Pharma (LTRN) United States $0.069B 0.00
Kronos Bio (KRON) United States $0.068B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
Equillium (EQ) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
HCW Biologics (HCWB) United States $0.064B 0.00
Checkpoint Therapeutics (CKPT) United States $0.064B 0.00
Genenta Science S.p.A (GNTA) Italy $0.063B 0.00
Intensity Therapeutics (INTS) United States $0.063B 0.00
Kezar Life Sciences (KZR) United States $0.063B 0.00
Vaxxinity (VAXX) United States $0.062B 0.00
Immuneering (IMRX) United States $0.061B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
NextCure (NXTC) United States $0.054B 0.00
Bionano Genomics (BNGO) United States $0.053B 0.00
Beyond Air (XAIR) United States $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Apollomics (APLM) United States $0.050B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.050B 0.00
Carmell (CTCX) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.048B 0.00
CalciMedica (CALC) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.047B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Clene (CLNN) United States $0.046B 0.00
Bolt Biotherapeutics (BOLT) United States $0.046B 0.00
Ocuphire Pharma (OCUP) United States $0.046B 0.00
Promis Neurosciences (PMN) Canada $0.044B 0.00
SAB Biotherapeutics (SABS) United States $0.043B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Quince Therapeutics (QNCX) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.040B 0.00
BRIACELL THERAP (BCTX) Canada $0.040B 0.00
Semper Paratus Acquisition (TVGN) United States $0.039B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
IN8bio (INAB) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Theratechnologies (THTX) Canada $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Prenetics Global (PRE) Cayman Islands $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.034B 0.00
Aprea Therapeutics (APRE) United States $0.031B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Spruce Biosciences (SPRB) United States $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.028B 0.00
Lexaria Bioscience (LEXX) Canada $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.027B 0.00
Sensei Biotherapeutics (SNSE) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Eyenovia (EYEN) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
KALA BIO (KALA) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.018B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
Purple Biotech (PPBT) Israel $0.016B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Imunon (IMNN) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Benitec Biopharma (BNTC) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Telesis Bio (TBIO) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
NuCana (NCNA) United Kingdom $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Virios Therapeutics (VIRI) United States $0.010B 0.00
TFF Pharmaceuticals (TFFP) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Galera Therapeutics (GRTX) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
First Wave BioPharma (FWBI) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Seelos Therapeutics (SEEL) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.35
Artelo Biosciences (ARTL) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Kineta (KA) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00